Frihamnsenteret
Skånevik, Norway
NCT Number: NCT00860236
A giardiasis outbreak in Bergen has given us the opportunity to approach two basic research questions of national and global importance:
* Studying the pathoimmunology of giardiasis in a natural setting, and following the genetic and immunological responses leading to recovery or persistent disease and sequelae. * Studying the two disease entities FGID and CFS when induced by acute giardiasi and their risk factors. * Interventional cognitive behavioural therapy is the only intervention documented to have significant effect on CFS outcome, and conventional cognitive behavioural therapy will be compared to a psycho-educational programme in the format of a randomised controlled trial.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
Skånevik, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
2 days of education on mechanisms of illness and coping strategies
4 days intensive training in understanding and behavioural changes
Other names: CBT
Time frame: 6 months
University of Bergen
Other
Chronic Fatigue Syndrome and Abdominal Symptoms After Giardia Infection: Clinical Evaluation, Biomarkers, Risk Factors and the Effect of Intervention
Acronym: GIFF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05273372
Chronic Disease, Chronic Fatigue Syndrome
Salt Lake City, Utah, United States
View Trial DetailsNCT03075254
Chronic Disease, Chronic Fatigue Syndrome
Gainesville, Florida, United States
View Trial DetailsNCT03691987
Chronic Disease, Chronic Fatigue Syndrome
Harstad, Troms, Norway
View Trial DetailsNCT05973136
Behavior, COVID-19
Sherbrooke, Quebec, Canada
View Trial Details